Predictors for heparin resistance in patients undergoing coronary artery bypass grafting

Abstract

Heparin resistance (HR) is a common event in cardiac operations. At present, no clear recognition of the risk factors for HR has been reached. The aim of this study was to determine a predictive model for HR, based on the preoperative patient’s profile. Two hundred consecutive patients scheduled for elective coronary artery bypass operations were enrolled in a prospective trial. Demographics, type of preoperative anticoagulation therapy and preoperative coagulation profile were collected and statistically analysed with respect to the evidence of a HR. Heparin resistance was defined as at least one activated clotting time < 400 s after heparinization and/or the need for purified antithrombin III (AT-III) administration. With a multivariate analysis we could identify five predictors for HR: AT-III ≤ 60%; preoperative subcutaneous heparin therapy; intravenous heparin therapy; platelet count ≥ 300 000 cells/mm³; age ≥ 65 years. We conclude that HR is a predictable event. In the presence of all the risk factors, the likelihood of HR is 99%; in the absence of all of them, it is 10%. Predicting HR allows us to apply many possible therapeutic strategies.

Get full access to this article

View all access options for this article.

References

Esposito RA , Culliford AT , Colvin SB , Thomas SJ , Lackner H , Spencer, FC. Heparin resistance during cardiopulmonary bypass: the role of heparin pretreatment . J Thorac Cardiovasc Surg 1983; 85: 346-353 .

Kamath BSK , Fozard JR. Control of heparinization during cardiopulmonary bypass . Anaesthesia 1980; 35: 250-256 .

Soloway HB , Christiansen TW. Heparin anticoagulation during cardiac surgery in AT-III deficient patients . Am J Clin Pathol 1980; 73: 723-725 .

Chung F , David TE , Watt J. Excessive requirement of heparin during cardiac surgery . Can Anaesth Soc J 1981; 28: 280-282 .

Mabry CD , Read RC , Thompson BW , Williams GD , White HJ. Identification of heparin resistance during cardiac and vascular surgery . Arch Surg 1979; 114: 128-135 .

Dietrich W , Spannagl M , Schramm W , Vogt W , Barankay A , Richter JA. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass . J Thorac Cardiovasc Surg 1991; 102: 505-514 .

Staples MH , Dunton RF , Karlson KJ , Leonardi HK , Berger RL. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping . Ann Thorac Surg 1994; 57: 1211-1216 .

Cloyd GM , D’Ambra MN , Akins CW. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting . J Thorac Cardiovasc Surg 1987; 94: 535-538 .

Conard J , LeCompte T , Horellou MH , Cazenave B , Sanama M. AT-III in patients treated with subcutaneous or intravenous heparin . Thromb Res 1981; 22: 507-511 .

10.

Ansell J , Deykin D. Heparin induced thrombocytopenia and recurrent thromboembolism . Am J Hematol 1980; 8: 325-332 .

11.

Denson KE. Ratio of Factor VIII-related antigen and Factor VIII biological activity as an index of hypercoagulability and intravascular clotting . Thromb Res 1977; 10: 107-119 .

12.

Cleveland WS. Robust locally weighted regression and smoothing scatterplots . J Am Stat Assoc 1979; 74: 829-836 .

13.

Hashimoto K , Yamagishi M , Sasaki T , Nakano M , Kurosawa H. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation . Ann Thorac Surg 1995; 58: 799-805 .

14.

Despotis GJ , Levine V , Joist JH , Joiner-Maier D , Spitznagel E. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation . Anesth Analg 1997; 85: 498-506 .

15.

Marciniak E , Gockerman JP. Heparin-induced decrease in circulating antithrombin-III . Lancet 1977; 2: 581-584 .

16.

Bull BS , Korpman RA , Huse WM , Briggs BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols . J Thorac Cardiovasc Surg 1975; 69: 685-689 .

17.

Horne MK , Chao SC. Heparin binding to resting and activated platelets . Blood 1989; 74: 238-243 .

18.

John LCH , Rees GM , Kovacs IB. Reduction of heparin binding to and inhibition of platelets by aprotinin . Ann Thorac Surg 1993; 55: 1175-1179 .

19.

Conlan MG , Folsom AR , Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis . Thromb Haemost 1993; 70: 380-385 .